Does CPAP lower blood pressure: what the meta-analyses actually show

Does CPAP lower blood pressure: what the meta-analyses actually show

“Does CPAP lower blood pressure” is one of the most common questions an OSA patient asks after a fresh diagnosis, and the honest answer requires distinguishing average effect from individual response, and distinguishing CPAP used adequately from CPAP used nominally. The published meta-analyses converge on a modest average blood-pressure reduction of roughly 2–3 mmHg systolic. The tails

Obstructive vs central vs complex sleep apnea — and why the distinction matters

Obstructive vs central vs complex sleep apnea — and why the distinction matters

A patient with a OSA vs CSA, PSG showing AHI 28 is told “you have sleep apnea” and is prescribed CPAP. The prescription may be correct. It may also be wrong — fatal-level wrong in rare cases — if the events were predominantly central, or if they convert to central on CPAP initiation. The difference between

Heated tubing on CPAP: what the evidence actually supports

Heated tubing on CPAP: what the evidence actually supports

heated CPAP tubing is the most common upsell at the point of CPAP purchase, and it is one of the few accessories where the cost-benefit calculation genuinely depends on where the patient sleeps, not just on what the patient spends. Roughly ₹3,000–8,000 separates a standard hose from the matched heated-tube option across ResMed ClimateLine, Philips Heated Tube

CPAP leak types — intentional, mask leak, mouth leak, and how to diagnose each

CPAP leak types — intentional, mask leak, mouth leak, and how to diagnose each

“Leak” is printed on the CPAP report in red if it crosses a threshold and in a calm colour if it doesn’t. What the report doesn’t tell the patient — or the dealer who just handed over the machine — is that the number is a composite of three very different phenomena, CPAP leak types and

EPR, C-Flex, A-Flex, Bi-Flex — exhalation pressure relief explained

EPR, C-Flex, A-Flex, Bi-Flex — exhalation pressure relief explained

At  homemedix , patient who cannot tolerate a CPAP exhalation pressure relief at 12 cmH₂O often tolerates the same prescription with pressure relief during exhalation — the machine drops the pressure by 1–3 cmH₂O for the expiratory phase, letting the patient breathe out against a lower pressure before the next inspiration reinstates the full prescribed value. This feature, under various

CPAP side effects and management: aerophagia, dry mouth, leaks, and claustrophobia

CPAP side effects and management: aerophagia, dry mouth, leaks, and claustrophobia

CPAP therapy is well-tolerated for most patients after a 2–4 week acclimation period, but a substantial minority CPAP side effects encounter side effects that, if not resolved, become adherence failures. Almost every side effect has a standard clinical solution, and the solutions are not obscure — they involve pressure adjustment, mask swap, humidification tuning, or graduated desensitisation.

CPAP for stroke recovery patients: evidence and initiation

CPAP for stroke recovery patients: evidence and initiation

Stroke and sleep apnea have a two-way relationship that clinicians have understood for two decades but Indian practice is still catching up to. Untreated obstructive CPAP for stroke recovery patients sleep apnea is an independent risk factor for ischaemic stroke, and stroke itself — particularly when it affects the brainstem, insular cortex, or upper airway motor control

CPAP compliance evidence: what the data shows about who sticks with therapy

CPAP compliance evidence: what the data shows about who sticks with therapy

 A CPAP prescription written is not a CPAP therapy delivered. Between the prescription and the clinical benefit sits a long, thin corridor called adherence, and the published data on how many patients successfully walk through that corridor is sobering. This article summarises the compliance evidence base — how the 4 hours per night, 70% of

CPAP and PAP therapy in heart failure: what to use and what to avoid

CPAP and PAP therapy in heart failure: what to use and what to avoid

Roughly half of HFrEF patients, screened by polysomnography, have clinically significant sleep-disordered breathing. The phenotype is usually mixed: Heart failure and sleep-disordered breathing share a bidirectional relationship with meaningful prescribing consequences. A patient with heart failure with reduced ejection fraction (HFrEF, LVEF ≤ 45%) is likely to CPAP therapy for heart failure exhibit some combination

  • 1
  • 2